First Update On The Brazilian Consensus For The Diagnosis And Treatment Of Spondyloarthropathies: Ankylosing Spondylitis And Psoriatic Arthritis [consenso Brasileiro Den Espondiloartropatias: Espondilite Anquilosante E Artrite Psoriásica Diagnóstico E Tratamento - Primeira Revisão]

dc.creatorSampaio-Barros P.D.
dc.creatorAzevedo V.F.
dc.creatorBonfiglioli R.
dc.creatorCampos W.R.
dc.creatorCarneiro S.C. da S.
dc.creatorCarvalho M.A.P.
dc.creatorGoncalves C.R.
dc.creatorHilario M.O.E.
dc.creatorKeiserman M.W.
dc.creatorLeite N.H.
dc.creatorMallmann K.
dc.creatorMeirelles E. de S.
dc.creatorVieira W.P.
dc.creatorXimenes A.C.
dc.date2007
dc.date2015-06-30T18:47:40Z
dc.date2015-11-26T14:36:03Z
dc.date2015-06-30T18:47:40Z
dc.date2015-11-26T14:36:03Z
dc.date.accessioned2018-03-28T21:39:34Z
dc.date.available2018-03-28T21:39:34Z
dc.identifier
dc.identifierRevista Brasileira De Reumatologia. , v. 47, n. 4, p. 233 - 242, 2007.
dc.identifier4825004
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-51449087847&partnerID=40&md5=ef34a195c306d695c647ea6ac417e9ed
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/104819
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/104819
dc.identifier2-s2.0-51449087847
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1248566
dc.description[No abstract available]
dc.description47
dc.description4
dc.description233
dc.description242
dc.descriptionMoll, J.H.M., Haslock, I., MacRae, I., Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's Psease, the intestinal arthropathies, and Behcet's syndrome (1974) Medicine, 53, pp. 343-364
dc.descriptionBraun, J., Sieper, J., (2002) Building consensus on nomenclature and disease classification for ankylosing spondylitis: Results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002. Ann Rheum Dis 61(Supl. III):61-7
dc.descriptionDougados, M., van der Linden, S., Juhlin, R., The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy (1991) Arthritis Rheum, 34, pp. 1218-1227
dc.descriptionVan der Linden, S., Van der Heijde, D., Ankylosing spondylitis: Clinical features (1998) Rheum Dis Clin North Am, 24, pp. 663-676
dc.descriptionCalin, A., Elswood, J., Rigg, S., Skevington, S.M., Ankylosing spondylitis - An analytical review of 1,500 patients: The changing pattern of the disease (1988) J Rheumatol, 15, pp. 1234-1238
dc.descriptionReveille, J.D., Ball, E.J., Khan, M.A., HLA-B27 and genetic predisposing factors in spondyloarthropathies (2001) Curr Opin Rheumatol, 13, pp. 265-272
dc.descriptionSampaio-Barros, P.D., Bertolo, M.B., Kraemer, M.H., Primary ankylosing spondylitis: Patterns of disease in a Brazilian population of 147 patients (2001) J Rheumatol, 28, pp. 560-565
dc.descriptionWang SW, Davis JC Jr.: Clinical aspects of ankylosing spondylitis. In: Weisman MH, Reveille JD, van der Heijde D (eds). Ankylosing spondylitis and the spondyloarthropathies. Philadelphia: Mosby Elsevier, 2006;145-53Van der Linden, S., Valkenburg, H.A., Cats, A., Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria (1984) Arthritis Rheum, 27, pp. 361-368
dc.descriptionVan der Heijde D, Landewe R: Assessment of disease activity, function, and quality of life. In: Weisman MH, Reveille JD, van der Heijde D (eds). Ankylosing spondylitis and the spondyloarthropathies. Philadelphia: Mosby Elsevier, 2006
dc.description206-13Braun J, Baraliakos X: Imaging in ankylosing spondylitis. In: Weisman MH, Reveille JD, van der Heijde D (eds). Ankylosing spondylitis and the spondyloarthropathies. Philadelphia: Mosby Elsevier, 2006;187-204Garrett, S., Jenkinson, T., Kennedy, L.G., Whitelock, H., Gaisford, P., Calin, A., A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index (1994) J Rheumatol, 21, pp. 2286-2291
dc.descriptionCusmanich, K.G., (2006) Validação para a língua portuguesa dos instrumentos de avalição de índice funcional e índice de atividade de doença em pacientes com espondilite anquilosante, , Dissertação de Mestrado em Ciências, Faculdade de Medicina da Universidade de São Paulo. Banco de Tese Capes
dc.descriptionCalin, A., Garrett, S., Whitelock, H., A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index (1994) J Rheumatol, 21, pp. 2281-2285
dc.descriptionShinjo, S.K., Goncalves, R., Kowalski, S., Goncalves, C.R., Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: A translation, cross-cultural adaptation, and validation (2007) Clin Rheumatol, 26, pp. 1254-1258
dc.descriptionDagfιnrud, H., Kvien, T.K., Hagen, K.B., The Cochrane review of physiotherapy interventions for ankylosing spondylitis (2005) J Rheumatol, 32, pp. 1899-1906
dc.descriptionClegg, D.O., Treatment of ankylosing spondylitis (2006) J Rheumatol, 33 (SUPL. 78), pp. 24-31
dc.descriptionVan der Heijde, D., Baraf, H.S., Ramos-Remus, C., Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty-two-week, randomized, controlled study (2005) Arthritis Rheum, 52, pp. 1205-1215
dc.descriptionBarkhuizen, A., Steinfeld, S., Robbins, J., West, C., Coombs, J., Zwillich, S., Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis (2006) J Rheumatol, 33, pp. 1805-1812
dc.descriptionWanders, Van der Heijde D, Landewé R, et al.: Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52:1756-65, 2005Ward, M.M., Prospects for disease modification in ankylosing spondylitis: Do nonsteroidal antiinflammatory drugs do more than treat symptoms? (2005) Arthritis Rheum, 52, pp. 1634-1636
dc.descriptionDougados, M., Dujkmans, B., Khan, M., Maksymowych, W., Van der Linden, S., Brandt, J., Conventional treatments for ankylosing spondylitis (2002) Ann Rheum Dis, 61 (SUPL. III), pp. 40-50
dc.descriptionPeters, N.D., Ejstrup, L., Intravenous methylprednisolone pulse therapy in ankylosing spondylitis (1992) Scand J Rheumatol, 21, pp. 134-138
dc.descriptionBraun, J., Bollow, M., Seyrekbasan, F., Computed tomography guided corticosteroid injection of sacroliac joint in patients with spondyloarthropathy with sacroiliitis: Clinical outcome and followup by dynamic magnetic resonance imaging (1996) J Rheumatol, 23, pp. 659-664
dc.descriptionGratacós, J., Collado, A., Pons, F., Significant loss of bone mass in patients with early, active, ankylosing spondylitis: A followup study (1999) Arthritis Rheum, 42, pp. 2319-2324
dc.descriptionMitra, D., Elvins, D.M., Speden, D.J., Collins, A.J., Prevalence of vertebral compression fractures in mild ankylosing spondylitis and their relationship to bone mineral density (2000) Rheumatology 39-85-9
dc.descriptionZochling, J., Van der Heijde, D., Burgos-Vargas, R., ASAS/EULAR recommendations for the management of anklosing spondylitis (2006) Ann Rheum Dis, 65, pp. 442-452
dc.descriptionDougados, M., van der Linden, S., Leirisalo-Repo, M., Sulfasalazine in the treatment of spondylarthropathy: A randomized multicenter, double-blind, placebo-controlled study (1995) Arthritis Rheum, 38, pp. 618-627
dc.descriptionBenitez-del-Castilho, J.M., Garcia-Sanchez, J., Iradier, T., Bañares, A., Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis (2000) Eye, 14, pp. 340-343
dc.descriptionChen, J., Liu, C., Sulfasalazine for ankylosing spondylitis (2005) Cochrane Database Syst Rev, 18 (2). , CD004800
dc.descriptionSampaio-Barros, P.D., Costallat, L.T.L., Bertolo, M.B., Marques Neto, J.F., Samara, A.M., Methotrexate in the treatment of ankylosing spondylitis (2000) Scand J Rheumatol, 29, pp. 160-162
dc.descriptionChen, J., Liu, C., Lin, J., Methotrexate for ankylosing spondylitis (2006) Cochrane Database Syst Rev, 18 (4). , CD004524
dc.descriptionAkkoc, N., van der Linden, S., Khan, M.A., Ankylosing spondylitis and symptom-modifying vs. disease modifying therapy (2006) Best Pract Res Clin Rheumatol, 20, pp. 539-557
dc.descriptionHuang, F., Gu, J., Zhao, W., Zhu, J., Zhang, J., Yu, D.T.Y., One year open label trial of thalidomide in ankylosing spondylitis (2002) Arthritis Rheum, 47, pp. 249-254
dc.descriptionMaksymowych, W.P., Jhangri, G.S., Fitzgerald, A., A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis (2002) Arthritis Rheum, 46, pp. 766-773
dc.descriptionVan den Bosch, F., Kruithof, E., Baeten, D., Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy (2002) Arthritis Rheum, 46, pp. 755-765
dc.descriptionKruithof, E., Van den Bosch, F., Baeten, D., Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: One year follow up (2002) Ann Rheum Dis, 61, pp. 207-212
dc.descriptionBraun, J., Landewe, R., Hermann, K.-G., Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study (2006) Arthritis Rheum, 54, pp. 1646-1652
dc.descriptionBraun, J., Brandt, J., Listing, J., Treatment of ankylosing spondylitis with infliximab: A randomized controlled multicentre trial (2002) Lancet, 359, pp. 1187-1193
dc.descriptionBraun, J., Brandt, J., Listing, J., Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis (2003) Arthritis Rheum, 48, pp. 2224-2233
dc.descriptionBraun, J., Baraliakos, X., Listing, J., Sieper, J., Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept (2005) Arthritis Rheum, 52, pp. 2447-2451
dc.descriptionBraun, J., Baraliakos, X., Brandt, J., Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years (2005) Rheumatology, 44, pp. 670-676
dc.descriptionBaraliakos, X., Listing, J., Brandt, J., Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (2005) Arthritis Res Ther, 7, pp. R439-R444
dc.descriptionBaraliakos, X., Listing, J., Rudwaleit, M., Safety and efficacy of readministration of infliximab after long-term continuous therapy and withdrawal in patients with ankylosing spondylitis (2007) J Rheumatol, 34, pp. 510-515
dc.descriptionBrandt, J., Khariouzov, A., Listing, J., Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis (2003) Arthritis Rheum, 48, pp. 1667-1675
dc.descriptionDavis Jr., J.C., van der Heijde, D., Braun, J., Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized controlled trial (2003) Arthritis Rheum, 48, pp. 3230-3236
dc.descriptionMaksymowych, W.P., Poole, A.R., Hiebert, L., Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis (2005) J Rheumatol, 32, pp. 1911-1917
dc.descriptionBaraliakos, X., Brandt, J., Listing, J., Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data (2005) Arthritis Rheum, 53, pp. 856-863
dc.descriptionDavis, J.C., Van der Heijde, D., Braun, J., Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks (2005) Ann Rheum Dis, 64, pp. 1557-1562
dc.descriptionVan der Heijde, D., Da Silva, J.C., Dougados, M., Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis (2006) Ann Rheum Dis, 65, pp. 1572-1577
dc.descriptionVan der Heijde, D., Kivitz, A., Schiff, M.H., Efficacy and safety of adalimumab in patients with ankylosing spondylitis (2006) Arthritis Rheum, 54, pp. 2136-2146
dc.descriptionHaibel, H., Rudwaleit, M., Brandt, H.C., Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty-two-week open-label trial (2006) Arthritis Rheum, 54, pp. 678-681
dc.descriptionBraun, J., Davis, J., Dougados, M., First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis (2006) Ann Rheum Dis, 65, pp. 316-320
dc.descriptionCarmona, L., Gomez-Reino, J.J., Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER (2006) Arthritis Res Ther, R72. , on behalf of the BIOBADASER Group
dc.descriptionRudwaleit, M., Listing, J., Brandt, J., Braun, J., Sieper, J., Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis (2004) Ann Rheum Dis, 63, pp. 665-670
dc.descriptionDelaunay, C., Farrenq, V., Marini-Portugal, A., Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: Preliminary data (2005) J Rheumatol, 32, pp. 2183-2185
dc.descriptionMoll, J.M.H., Wright, V., Psoriatic arthritis (1973) Semin Arthritis Rheum, 3, pp. 55-78
dc.descriptionGladman, D.D., Antoni, C., Mease, P., Clegg, D.O., Nash, P., Psoriatic arthritis: Epidemiology, clinical features, course, and outcome (2005) Ann Rheum Dis, 64 (SUPL. II), pp. ii14-ii17
dc.descriptionGriffiths CEM, Camp RDR, Barker JN: Psoriasis. In: Champion RH, Burton JL, Burns DA, et al. Rook/Wilkinson/Ebling Textbook of dermatology. 7a ed. Oxford: Blackwell Science, 2004;35.1-65Espinoza, L.R., Cuellar, M.L., Psoriatic arthritis and spondylitis: A clinical approach (1998) Spondylarthritides, pp. 97-111. , Calin A, Taurog JD editors, Oxford: Oxford University Press
dc.descriptionMease, P., Goffe, B.S., Diagnosis and treatment of psoriatic arthritis (2005) J Am Acad Dermatol, 52, pp. 1-19
dc.descriptionBalding, J., Kane, D., Livingstone, W., Cytokine gene polymorphisms: Association with psoriatic arthritis susceptibility and severity (2003) Arthritis Rheum, 48, pp. 1408-1413
dc.descriptionSibilia, J., Psoriasis: Skin and joints, same fight? (2006) JEADV, 20 (SUPL. 2), pp. 56-72
dc.descriptionVeale, D., Ritchlin, C., Fitz Gerald, O., Immunopathology of psoriasis and psoriatic arthritis (2005) Ann Rheum Dis, 65, pp. 26-29
dc.descriptionTaylor, W., Gladman, D., Helliwell, P., Classification criteria for psoriatic arthritis: Development of new criteria from a large international study (2006) Arthritis Rheum, 54, pp. 2665-2673
dc.descriptionKhan, M.-F., Chamot, A.-M., SAPHO syndrome (1992) Rheum Dis Clin North Am, 18, pp. 225-246
dc.descriptionKavanaugh AF, Ritchlin CT, and the GRAPPA Treatment Guideline Committee: Systematic review of treatment for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 33:1417-21, 2006Greaves, M.W., Weinstein, G.D., Treatment of psoriasis (1995) New Engl J Med, 332, pp. 581-588
dc.descriptionGladman, D.D., Effectiveness of psoriatic arthritis therapies (2003) Semin Arthritis Rheum, 33, pp. 29-37
dc.descriptionTsankov, N., Kazandjieva, J., Drenovska, K., Drugs in exacerbation and provocation of psoriasis (1998) Clin Dermatol, 16, pp. 333-351
dc.descriptionSoriano, E.R., McHugH, N.J., Therapies for peripheral joint disease in psoriatic arthritis: A systematic review (2006) J Rheumatol, 33, pp. 1422-1430
dc.descriptionEspinoza, L.R., Zakraoui, I., Espinoza, C.G., Psoriatic arthritis: Clinical response and side effects to methotrexate therapy (1992) J Rheumatol, 19, pp. 872-877
dc.descriptionTilling, L., Townsend, S., David, J., Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis (2006) Clin Drug Investig, 26, pp. 55-62
dc.descriptionClegg, D.O., Reda, R.J., Mejias, E., Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis: A Department of Veterans Affairs Cooperative Study (1996) Arthritis Rheum, 39, pp. 2013-2020
dc.descriptionOlivieri, I., Salvarani, C., Cantini, F., Therapy with cyclosporine in psoriatic arthritis (1997) Semin Arthritis Rheum, 27, pp. 36-43
dc.descriptionSpadaro, A., Riccieri, V., Silli-Scavalli, A., Sensis, F., Taccari, E., Zoppini, A., Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: A one-year prospective study (1995) Clin Exp Rheumatol, 13, pp. 589-593
dc.descriptionSalvarani, C., Macchioni, P., Olivieri, I., A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis (2001) J Rheumatol, 28, pp. 2274-2282
dc.descriptionFraser, A.D., van Kujik, A.W.R., Westhovens, R., A randomised, double-blind, placebo-controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis (2005) Ann Rheum Dis, 64, pp. 859-864
dc.descriptionKaltwasser, J.P., Nash, P., Gladman, D., Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial (2004) Arthritis Rheum, 50, pp. 1939-1950
dc.descriptionKavanaugh, A., Krueger, G.G., Beutler, A., Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: Results from the IMPACT 2 trial (2007) Ann Rheum Dis, 66, pp. 498-505
dc.descriptionKavanaugh, A., Antoni, C.E., Gladman, D., The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): Results of radiographic analyses after 1 year (2006) Ann Rheum Dis, 65, pp. 1038-1043
dc.descriptionMease, P.J., Kivitz, A.J., Burch, F.X., Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression (2004) Arthritis Rheum, 50, pp. 2264-2272
dc.descriptionMease, P.J., Kivitz, A.J., Burch, F.X., Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept (2006) J Rheumatol, 33, pp. 712-721
dc.descriptionGladman, D.D., Mease, P.J., Ritchlin, C.T., Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial (2007) Arthritis Rheum, 56, pp. 476-488
dc.descriptionTurkiewicz, A.M., Moreland, L.W., Psoriatic arthritis: Current concepts on pathogenesis-oriented therapeutic options (2007) Arthritis Rheum, 56, pp. 1051-1066
dc.languagept
dc.publisher
dc.relationRevista Brasileira de Reumatologia
dc.rightsfechado
dc.sourceScopus
dc.titleFirst Update On The Brazilian Consensus For The Diagnosis And Treatment Of Spondyloarthropathies: Ankylosing Spondylitis And Psoriatic Arthritis [consenso Brasileiro Den Espondiloartropatias: Espondilite Anquilosante E Artrite Psoriásica Diagnóstico E Tratamento - Primeira Revisão]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución